EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review

Pooneh Jabbaripour Sarmadian iD, Amir Dolatshahi Pirooz, Maha Al Baghdadi, Mohammad Kamgar, Yalda Afshar iD, Niloofar Nobakht iD

Journal of Pregnancy · 2026-01 · 2026 (1)

DOI: 10.1155/jp/9166037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pregnancy, online erschienen am 19.07.2026. Verfasst von Pooneh Jabbaripour Sarmadian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, jhu.edu. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Pregnancy Complications. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder and an important cause of kidney failure among individuals of reproductive age. Although its management in nonpregnant adults is well established, the implications of ADPKD during pregnancy remain less clearly defined. The aim of this review is to summarize maternal and fetal risks and provide practical management considerations for pregnancy in individuals with ADPKD.

Methods

A narrative review of the literature was conducted using PubMed/MEDLINE and relevant clinical practice guidelines, focusing on pregnancy‐related outcomes and management considerations in individuals with ADPKD.

Results

Pregnant individuals with ADPKD face higher risks of chronic hypertension, proteinuria, hypertensive disorders of pregnancy, and preterm delivery compared with the general population. Strict blood pressure targets used outside of pregnancy may compromise uteroplacental perfusion, highlighting the importance of pregnancy‐appropriate goals and safe antihypertensive choices. Renin–angiotensin system inhibitors and disease‐modifying therapies such as tolvaptan are contraindicated due to fetal safety concerns. Monitoring strategies include regular assessment of blood pressure, kidney function, and fetal growth. Emerging imaging data suggest that pregnancy may accelerate kidney and liver cyst growth, although long‐term consequences remain uncertain. Additional strategies such as low‐dose aspirin, biochemical markers for preeclampsia risk assessment, and renal ultrasound for baseline evaluation may be considered.

Conclusion

Pregnancy in individuals with ADPKD requires individualized, multidisciplinary care with careful attention to blood pressure control, medication safety, and maternal and fetal monitoring. Further research is needed to better understand long‐term outcomes and optimize management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantPregnancy ComplicationsHumansFemalePregnancyPregnancy Outcome

Stichwörter der Autor:innen

ADPKDhypertensionmaternal outcomespreeclampsiapregnancy

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, jhu.edu.
  • Beverly Hills Cancer Center, Clinical Research, Los Angeles, California, USA.
  • Division of Nephrology, Department of Medicine, Kaiser Permanente Downey Medical Center, Downey, California, USA.
  • Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA, ucla.edu.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA, ucla.edu.

ORCID-Profile: Pooneh Jabbaripour Sarmadian, Yalda Afshar, Niloofar Nobakht

Zitieren

APA

Sarmadian, P. J., Pirooz, A. D., Al Baghdadi, M., Kamgar, M., Afshar, Y., & Nobakht, N. (2026). Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review. Journal of Pregnancy, 2026(1). https://doi.org/10.1155/jp/9166037

Vancouver

Sarmadian PJ, Pirooz AD, Al Baghdadi M, Kamgar M, Afshar Y, Nobakht N. Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review. Journal of Pregnancy. 2026;2026(1). doi:10.1155/jp/9166037

BibTeX
@article{Sarmadian2026,
  author = {Sarmadian, Pooneh Jabbaripour and Pirooz, Amir Dolatshahi and Al Baghdadi, Maha and Kamgar, Mohammad and Afshar, Yalda and Nobakht, Niloofar},
  title = {Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review},
  journal = {Journal of Pregnancy},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jp/9166037}
}
Kostenlos starten →